Literature DB >> 20564465

Quantitative magnetic resonance fluorine imaging: today and tomorrow.

Junjie Chen1, Gregory M Lanza, Samuel A Wickline.   

Abstract

Fluorine (19F) is a promising moiety for quantitative magnetic resonance imaging (MRI). It possesses comparable magnetic resonance (MR) sensitivity to proton (1H) but exhibits no tissue background signal, allowing specific and selective assessment of the administrated 19F-containing compounds in vivo. Additionally, the MR spectra of 19F-containing compounds exhibited a wide range of chemical shifts (>200 ppm). Therefore, both MR parameters (e.g., spin-lattice relaxation rate R1) and the absolute quantity of molecule can be determined with 19F MRI for unbiased assessment of tissue physiology and pathology. This article reviews quantitative 19F MRI applications for mapping tumor oxygenation, assessing molecular expression in vascular diseases, and tracking labeled stem cells. Copyright (c) 2010 John Wiley & Sons, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20564465      PMCID： PMC4296973          DOI： 10.1002/wnan.87

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN： 1939-0041


  72 in total

Review 1.  Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging.

Authors:  J A Frank; S A Anderson; H Kalsih; E K Jordan; B K Lewis; G T Yocum; A S Arbab
Journal:  Cytotherapy       Date:  2004       Impact factor: 5.414

Review 2.  19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance.

Authors:  Jian-xin Yu; Vikram D Kodibagkar; Weina Cui; Ralph P Mason
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.

Authors:  S Hunjan; D Zhao; A Constantinescu; E W Hahn; P P Antich; R P Mason
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

4.  Potential role of PFOB in diagnostic imaging.

Authors:  R F Mattrey; D C Long
Journal:  Invest Radiol       Date:  1988-09       Impact factor: 6.016

5.  Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.

Authors:  Ali S Arbab; Gene T Yocum; Ali M Rad; Aarif Y Khakoo; Vicki Fellowes; Elizabeth J Read; Joseph A Frank
Journal:  NMR Biomed       Date:  2005-12       Impact factor: 4.044

6.  Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor.

Authors:  D Zhao; A Constantinescu; E W Hahn; R P Mason
Journal:  Radiat Res       Date:  2001-11       Impact factor: 2.841

Review 7.  Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Authors:  Megan M Kaneda; Shelton Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  Ann Biomed Eng       Date:  2009-01-30       Impact factor: 3.934

8.  Influence of perflubron emulsion particle size on blood half-life and febrile response in rats.

Authors:  P E Keipert; S Otto; S F Flaim; J G Weers; E A Schutt; T J Pelura; D H Klein; T L Yaksh
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  1994

9.  Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection.

Authors:  Jelena M Janjic; Mangala Srinivas; Deepak K K Kadayakkara; Eric T Ahrens
Journal:  J Am Chem Soc       Date:  2008-02-12       Impact factor: 15.419

10.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.

Authors:  Richard Southworth; Megan Kaneda; Junjie Chen; Lei Zhang; Huiying Zhang; Xiaoxia Yang; Reza Razavi; Gregory Lanza; Samuel A Wickline
Journal:  Nanomedicine       Date:  2009-01-19       Impact factor: 5.307
View more
  29 in total

Review 1.  Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.

Authors:  Junjie Chen; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

2.  Targeted inhibition of thrombin attenuates murine neonatal necrotizing enterocolitis.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Darla R Shores; Sunil K Jain; Jennifer Fundora; Allen D Everett; Ling He; Hua Pan; Samuel A Wickline; Akhil Maheshwari
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

Review 3.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

Review 4.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

5.  Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.

Authors:  Jeremy K Moore; Junjie Chen; Hua Pan; Joseph P Gaut; Sanjay Jain; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2017-11-16       Impact factor: 4.668

Review 6.  Targeted nanotechnology for cancer imaging.

Authors:  Randall Toy; Lisa Bauer; Christopher Hoimes; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2014-08-09       Impact factor: 15.470

7.  A symmetrical fluorous dendron-cyanine dye-conjugated bimodal nanoprobe for quantitative 19F MRI and NIR fluorescence bioimaging.

Authors:  Zhe Wang; Xuyi Yue; Yu Wang; Chunqi Qian; Peng Huang; Marty Lizak; Gang Niu; Fu Wang; Pengfei Rong; Dale O Kiesewetter; Ying Ma; Xiaoyuan Chen
Journal:  Adv Healthc Mater       Date:  2014-05-02       Impact factor: 9.933

Review 8.  Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.

Authors:  Matthias R Benz; Hebert Alberto Vargas; Evis Sala
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-09-26       Impact factor: 2.266

9.  Programmable nanoparticle functionalization for in vivo targeting.

Authors:  Hua Pan; Jacob W Myerson; Lingzhi Hu; Jon N Marsh; Kirk Hou; Michael J Scott; John S Allen; Grace Hu; Susana San Roman; Gregory M Lanza; Robert D Schreiber; Paul H Schlesinger; Samuel A Wickline
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

Review 10.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.